StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
434
This month
8
This week
3
This year
43
Publishing Date
2024 - 04 - 16
3
2024 - 02 - 14
4
2024 - 01 - 30
3
2023 - 12 - 06
3
2023 - 11 - 28
3
2023 - 09 - 06
3
2023 - 08 - 30
3
2023 - 05 - 19
3
2023 - 05 - 17
3
2023 - 04 - 14
4
2023 - 04 - 13
5
2023 - 03 - 28
3
2023 - 03 - 10
4
2023 - 02 - 27
4
2023 - 02 - 17
3
2023 - 02 - 08
3
2023 - 01 - 19
2
2023 - 01 - 11
2
2023 - 01 - 09
2
2023 - 01 - 04
2
2023 - 01 - 03
2
2022 - 12 - 05
2
2022 - 11 - 28
2
2022 - 11 - 21
3
2022 - 11 - 07
2
2022 - 10 - 06
3
2022 - 09 - 29
3
2022 - 09 - 27
2
2022 - 09 - 26
3
2022 - 09 - 23
2
2022 - 09 - 19
5
2022 - 09 - 09
2
2022 - 09 - 08
2
2022 - 09 - 07
2
2022 - 08 - 29
2
2022 - 08 - 25
2
2022 - 08 - 23
2
2022 - 08 - 17
2
2022 - 08 - 11
2
2022 - 06 - 29
2
2022 - 06 - 17
2
2022 - 06 - 09
2
2022 - 05 - 23
2
2022 - 05 - 18
2
2022 - 05 - 17
2
2022 - 05 - 09
2
2022 - 04 - 26
3
2022 - 04 - 04
2
2022 - 03 - 17
2
2022 - 03 - 16
2
2022 - 03 - 07
3
2022 - 02 - 09
2
2022 - 01 - 21
2
2022 - 01 - 18
2
2021 - 12 - 01
2
2021 - 10 - 27
2
2021 - 10 - 22
2
2021 - 10 - 21
3
2021 - 10 - 08
2
2021 - 10 - 01
2
Sector
Communications
6
Consumer durables
1
Consumer non-durables
11
Electronic technology
2
Finance
6
Finance and insurance
1
Health services
1
Health technology
434
Manufacturing
62
Mining, quarrying, and oil and gas extraction
1
N/a
57
Process industries
14
Producer manufacturing
9
Professional, scientific, and technical services
3
Retail trade
2
Technology services
1
Tags
Abbvie
4
Acne
6
Active
10
Agreement
4
Ajovy
6
Alliances
5
Alzheimer's
9
America
34
Application
5
Approval
5
Asia
11
Austedo
9
Avt04
6
Biosimilar
17
Business
9
Cancer
13
Care
6
Collaboration
6
Conference
11
Contraceptive
4
Contraceptives
4
Depression
4
Disease
29
Distribution
5
Doxorubicin
4
Drug
42
Drug delivery
6
Earnings
9
Events
8
Expected
11
Financial
13
Glaucoma
5
Global
100
Growing
16
Growth
116
Health
10
License
5
Liver
7
Market
276
Migraine
8
N/a
368
Pharm-country
15
Pharma
7
Pharmaceuticals
7
Reach
15
Report
82
Research
49
Respiratory
10
Results
18
Set
11
Skin
5
Stelara
6
Study
9
System
11
Teva
46
Therapeutics
53
Therapy
9
Treatment
58
Update
7
Year
5
Entities
3m company
938
Abb ltd
1427
Abbott laboratories
1787
Abbvie inc.
1024
Accenture plc
600
Alphabet inc.
781
Apple inc.
546
Arcelormittal
589
Arrival
586
Bank of montreal
539
Baxter international inc.
483
Becton, dickinson and company
796
Bnp paribas
654
Boston scientific corporation
575
Bristol-myers squibb company
662
Cisco systems, inc.
532
Cummins inc.
542
Danaher corporation
785
Dell technologies inc.
576
Dow inc.
556
Duke energy corporation
527
Eli lilly and company
1709
Ericsson
545
Express, inc.
509
Firstenergy corp.
517
Ford motor company
641
Gartner, inc.
594
General electric company
917
Glaxosmithkline plc
884
Honeywell international inc.
1787
Hubspot, inc.
1400
International business machines corporation
655
Johnson & johnson
4583
Johnson controls international plc
481
Koninklijke philips n.v.
962
Live nation entertainment, inc.
717
Lockheed martin corporation
575
Medtronic plc
1285
Microsoft corporation
807
Morgan stanley
4286
Nabors industries ltd.
480
Nokia corp
904
Nokia corporation
901
Northrop grumman corporation
589
Novartis ag
1241
Novo nordisk a/s
632
Ooma, inc.
488
Oracle corporation
1158
Orange
1423
Pfizer, inc.
692
S&p global inc.
500
Sanofi
1630
Sap se
1477
Snowflake inc.
796
Stellantis n.v
535
Stryker corporation
536
Thermo fisher scientific inc
1623
Transunion
533
Verizon communications inc.
1213
X financial
676
Symbols
ABBV
129
ABT
43
ALB
8
ALC
4
ALKS
5
ALPMF
27
ALPMY
27
ALVO
23
AMGN
74
ATR
5
ATRS
4
AZN
82
AZNCF
82
BAX
25
BDX
4
BHC
33
BIIB
28
BMY
37
CMXHF
6
CSLLY
6
CTIC
4
DNLI
5
ENDP
23
ENDPQ
15
FNCTF
6
GIFLF
4
GIKLY
4
GILD
10
GLAXF
147
GSK
147
IONS
4
JAZZ
6
JNJ
80
KMDA
23
LLY
61
MDT
9
MMM
9
MNK
14
MNKKQ
12
MNKPF
9
MS
5
NVO
15
NVS
206
NVSEF
206
PBH
4
PFE
29
PHG
12
PRGO
6
RBGLY
9
RBGPF
9
SNY
143
SNYNF
143
TAK
20
TARO
5
TEVA
64
TEVJF
434
TMO
8
UCBJF
7
UCBJY
7
VTRS
93
Exchanges
Nasdaq
631
Nyse
434
Crawled Date
2024 - 04 - 16
3
2024 - 02 - 14
4
2024 - 01 - 30
3
2023 - 12 - 06
3
2023 - 11 - 28
3
2023 - 08 - 30
3
2023 - 05 - 17
3
2023 - 04 - 14
4
2023 - 04 - 13
5
2023 - 03 - 28
3
2023 - 03 - 10
3
2023 - 02 - 27
4
2023 - 02 - 17
3
2023 - 02 - 09
2
2023 - 02 - 08
2
2023 - 01 - 21
2
2023 - 01 - 19
2
2023 - 01 - 12
2
2023 - 01 - 04
2
2023 - 01 - 03
2
2022 - 12 - 15
2
2022 - 12 - 05
2
2022 - 11 - 29
2
2022 - 11 - 21
3
2022 - 11 - 07
2
2022 - 10 - 06
3
2022 - 09 - 29
2
2022 - 09 - 27
2
2022 - 09 - 26
3
2022 - 09 - 23
2
2022 - 09 - 19
5
2022 - 09 - 09
2
2022 - 09 - 08
2
2022 - 09 - 07
2
2022 - 08 - 29
2
2022 - 08 - 25
2
2022 - 08 - 23
2
2022 - 08 - 17
2
2022 - 08 - 11
2
2022 - 06 - 29
2
2022 - 06 - 17
2
2022 - 06 - 09
2
2022 - 05 - 23
2
2022 - 05 - 18
2
2022 - 05 - 17
2
2022 - 05 - 09
2
2022 - 04 - 26
3
2022 - 04 - 04
2
2022 - 03 - 17
2
2022 - 03 - 16
2
2022 - 03 - 07
3
2022 - 03 - 02
2
2022 - 02 - 09
2
2022 - 01 - 21
2
2022 - 01 - 18
2
2021 - 12 - 01
2
2021 - 10 - 27
2
2021 - 10 - 21
3
2021 - 10 - 08
2
2021 - 10 - 01
2
Crawled Time
00:00
25
00:20
6
01:00
15
02:00
10
03:00
14
04:00
8
04:20
4
05:00
6
06:00
8
07:00
10
08:00
18
09:00
22
10:00
10
11:00
16
12:00
21
12:20
5
12:30
2
13:00
22
13:20
5
13:30
3
14:00
17
14:20
2
14:30
4
15:00
17
15:20
1
15:30
7
16:00
22
16:20
2
17:00
15
18:00
20
19:00
22
20:00
15
20:20
1
21:00
16
22:00
20
23:00
23
Source
www.biospace.com
66
www.globenewswire.com
22
www.prnewswire.com
346
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Teva pharmaceutical industries ltd
exchanges :
Nyse
save search
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published:
2024-04-16
(Crawled : 21:00)
- globenewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-0.08%
|
O:
-0.04%
H:
0.28%
C:
-0.16%
stelara
fda
biosimilar
approval
teva
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published:
2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-1.77%
|
O:
-0.53%
H:
0.0%
C:
-1.24%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
PHG
|
$19.98
0.0%
540K
|
Health Technology
|
-2.52%
|
O:
-1.21%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-2.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
VRNA
|
$15.82
-1.74%
-1.83%
640K
|
Health Technology
|
1.9%
|
O:
1.65%
H:
2.43%
C:
0.87%
reach
treatment
research
market
Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets
Published:
2024-04-16
(Crawled : 13:00)
- biospace.com/
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
-0.38%
|
O:
0.23%
H:
0.23%
C:
-1.28%
austedo
for
meeting
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
Published:
2024-04-11
(Crawled : 23:00)
- biospace.com/
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
-4.84%
|
O:
-1.01%
H:
2.04%
C:
1.17%
ajovy
for
teva
trial
migraine
china
results
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published:
2024-04-10
(Crawled : 09:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-10.96%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.16%
|
O:
-1.67%
H:
0.0%
C:
0.0%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-10.79%
|
O:
-0.29%
H:
0.0%
C:
-1.97%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-5.12%
|
O:
-0.6%
H:
1.03%
C:
0.52%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-9.54%
|
O:
-2.01%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.71%
|
O:
-1.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.25%
|
O:
-0.32%
H:
0.0%
C:
0.0%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
|
-7.38%
|
O:
-1.71%
H:
0.57%
C:
0.37%
disorders
system
set
market
Teva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024
Published:
2024-04-09
(Crawled : 23:00)
- biospace.com/
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
-7.18%
|
O:
-0.7%
H:
0.07%
C:
-0.92%
first
conference
teva
financial
results
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published:
2024-04-08
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.01%
|
O:
2.24%
H:
0.0%
C:
-0.8%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.57%
|
O:
-3.43%
H:
6.21%
C:
6.21%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
-5.76%
|
O:
-0.25%
H:
1.1%
C:
-0.17%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.83%
|
O:
-0.05%
H:
0.43%
C:
-0.27%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-5.88%
|
O:
-0.08%
H:
0.04%
C:
-0.35%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-16.04%
|
O:
0.38%
H:
0.0%
C:
-7.27%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-1.64%
|
O:
0.77%
H:
1.63%
C:
0.35%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.02%
|
O:
0.84%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
1.21%
|
O:
0.18%
H:
0.3%
C:
0.19%
eczema
dermatitis
set
therapeutics
market
Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate
Published:
2024-04-04
(Crawled : 00:00)
- biospace.com/
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
-6.66%
|
O:
-0.42%
H:
0.0%
C:
0.0%
candidate
biosimilar
global
for
teva
agreement
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-03-27
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-4.72%
|
O:
0.99%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.02%
|
O:
-1.17%
H:
0.0%
C:
-0.89%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
0.45%
|
O:
0.89%
H:
0.78%
C:
0.78%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-7.89%
|
O:
0.02%
H:
0.51%
C:
-0.3%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-9.3%
|
O:
0.26%
H:
2.03%
C:
1.57%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.42%
|
O:
0.36%
H:
0.72%
C:
0.61%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.06%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-8.47%
|
O:
-0.96%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.01%
|
O:
-0.12%
H:
0.25%
C:
-0.63%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.46%
|
O:
0.54%
H:
0.0%
C:
0.0%
abbvie
set
canada
key
market
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published:
2024-03-20
(Crawled : 20:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
-16.41%
|
O:
-1.58%
H:
1.87%
C:
0.53%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.83%
|
O:
-0.03%
H:
0.0%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-7.32%
|
O:
-0.89%
H:
0.0%
C:
0.0%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
-13.2%
|
O:
0.68%
H:
0.0%
C:
-1.86%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.97%
|
O:
0.58%
H:
1.2%
C:
0.84%
business
year
update
financial
results
Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published:
2024-03-11
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.45%
|
O:
2.01%
H:
0.0%
C:
-2.01%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.19%
|
O:
1.12%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-7.74%
|
O:
0.02%
H:
0.79%
C:
0.79%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
2.23%
|
O:
0.9%
H:
2.03%
C:
1.89%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-8.02%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.84%
|
O:
0.01%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.88%
|
O:
-0.19%
H:
0.22%
C:
-0.21%
global
set
growth
market
Global Fibrate Drugs Market Report 2024: A $5.14 Billion Market by 2034, Rising from S2.95 Billion in 2023
Published:
2024-03-11
(Crawled : 17:00)
- prnewswire.com
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-11.91%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.31%
|
O:
0.57%
H:
0.0%
C:
0.0%
report
global
market
Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging Population Fostering Growth
Published:
2024-02-28
(Crawled : 11:00)
- prnewswire.com
ROIV
|
$10.46
0.97%
0.96%
4.7M
|
Manufacturing
|
-11.53%
|
O:
-0.76%
H:
0.51%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.76%
|
O:
0.05%
H:
0.06%
C:
-0.95%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.41%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-7.61%
|
O:
0.6%
H:
0.02%
C:
-1.03%
global
set
dermatological
advanced
growth
market
Neuroblastoma Drugs Market to Reach $1.3 Billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research
Published:
2024-02-26
(Crawled : 15:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
4.77%
|
O:
3.06%
H:
0.0%
C:
-2.34%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-2.44%
|
O:
0.23%
H:
1.16%
C:
0.08%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-6.5%
|
O:
-0.19%
H:
0.23%
C:
-2.02%
UTHR
|
$237.99
0.45%
0.45%
400K
|
Health Technology
|
3.65%
|
O:
-0.48%
H:
1.17%
C:
-1.04%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
3.7%
|
O:
0.38%
H:
0.44%
C:
-0.23%
reach
research
market
United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published:
2024-02-22
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.97%
|
O:
0.37%
H:
0.58%
C:
0.58%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.46%
|
O:
0.89%
H:
0.4%
C:
0.17%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-2.45%
|
O:
0.57%
H:
0.47%
C:
-0.58%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-5.9%
|
O:
0.14%
H:
1.01%
C:
0.51%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.56%
|
O:
0.29%
H:
0.93%
C:
0.47%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.02%
|
O:
0.97%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-8.08%
|
O:
0.65%
H:
1.35%
C:
0.41%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.1%
|
O:
0.47%
H:
2.0%
C:
0.93%
pharmaceuticals
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-5.87%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
6.54%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.14%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
25.87%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-16.01%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.79%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.24%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-5.58%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
0.65%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-5.13%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.33%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.44%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.88%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-6.54%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
PARP Inhibitors Market to reach over USD 10.31 billion by the year 2031 - Exclusive Report by InsightAce Analytic
Published:
2024-02-21
(Crawled : 09:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
5.3%
|
O:
-0.88%
H:
1.75%
C:
-0.29%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.56%
|
O:
0.8%
H:
0.0%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.57%
|
O:
-0.25%
H:
0.0%
C:
0.0%
KPTI
|
$1.16
-9.38%
-10.34%
1.4M
|
Health Technology
|
5.79%
|
O:
-1.65%
H:
3.36%
C:
1.68%
CKPT
|
$1.47
-8.13%
-8.84%
760K
|
Health Technology
|
-14.65%
|
O:
0.0%
H:
1.26%
C:
-3.03%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
4.96%
|
O:
-1.01%
H:
1.1%
C:
1.1%
report
year
reach
market
Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual Meeting
Published:
2024-02-20
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.38%
|
O:
2.72%
H:
0.0%
C:
-0.8%
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
1.23%
|
O:
1.31%
H:
0.67%
C:
-0.91%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.56%
|
O:
2.53%
H:
0.0%
C:
0.0%
antibody
meeting
teva
Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published:
2024-02-15
(Crawled : 23:00)
- prnewswire.com
TRUMF
|
$16.928
-17.59%
1.9K
|
Health Technology
|
-53.57%
|
O:
0.79%
H:
0.0%
C:
-3.21%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.42%
|
O:
1.66%
H:
0.0%
C:
-1.59%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-5.89%
|
O:
1.66%
H:
0.0%
C:
-1.04%
TRUMY
|
$16.507
0.79%
34K
|
Manufacturing
|
-55.13%
|
O:
0.27%
H:
0.0%
C:
-2.6%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.57%
|
O:
0.37%
H:
0.57%
C:
0.19%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.21%
|
O:
-0.83%
H:
0.0%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.47%
|
O:
0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.15%
|
O:
-0.6%
H:
0.0%
C:
0.0%
drug
patent
report
review
global
advanced
market
Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
Published:
2024-02-15
(Crawled : 12:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
-18.92%
|
O:
0.32%
H:
2.98%
C:
0.32%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-7.24%
|
O:
-0.19%
H:
1.6%
C:
1.24%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
-15.22%
|
O:
1.66%
H:
1.96%
C:
0.49%
avt04
stelara
biosimilar
expected
global
market
← Previous
1
2
3
4
5
6
7
8
9
…
21
22
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.